Analystreport

Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Chardan Capital from $130.00 to $133.00.

Krystal Biotech, Inc.  (KRYS) 
Last krystal biotech, inc. earnings: 11/4 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.krystalbio.com/investors